DOMPE US INC.

Lobbying client · California · filed 2025 to 2025

Pharmaceutical Company.

$60,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (65033), not by name.

Firms hired 1

MASON STREET CONSULTING, LLC $60,000 4 filings

Reported by year 1 year

2025 $60,000 4 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Commerce, Dept of (DOC) 3
Health & Human Services, Dept of (HHS) 3
White House Office 3

Recent filings 5 total

3T

MASON STREET CONSULTING, LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Jan 18, 2026

View → Q3

MASON STREET CONSULTING, LLC Amended

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 6, 2025

View → Q2

MASON STREET CONSULTING, LLC

2nd Quarter (Apr 1 - June 30) 2025 · $30,000 income · posted Jul 8, 2025

View → Q1

MASON STREET CONSULTING, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · $30,000 income · posted Apr 10, 2025

View → RR

MASON STREET CONSULTING, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 20, 2025

View →

Foreign entities disclosed 1

DOMPE FARMACEUTICI S.P.A. Italy named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.